{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:05:15Z","timestamp":1784253915570,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00603","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T07:33:56Z","timestamp":1587627236000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Discovery of Retro-1 Analogs Exhibiting Enhanced Anti-vaccinia Virus Activity"],"prefix":"10.3389","volume":"11","author":[{"given":"Lalita","family":"Priyamvada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Alabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryaprakash","family":"Sambhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria A.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Sello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayampalli S.","family":"Satheshkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz002","article-title":"Monkeypox transmission among international travellers-serious monkey business?.","volume":"26","author":"Angelo","year":"2019","journal-title":"J. Travel Med."},{"key":"B2","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1128\/JVI.65.11.5910-5920.1991","article-title":"Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.","volume":"65","author":"Blasco","year":"1991","journal-title":"J. Virol."},{"key":"B3","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/JVI.66.7.4170-4179.1992","article-title":"Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.","volume":"66","author":"Blasco","year":"1992","journal-title":"J. Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1016\/j.bmc.2014.06.053","article-title":"Structural optimization of a retrograde trafficking inhibitor that protects cells from infections by human polyoma- and papillomaviruses.","volume":"22","author":"Carney","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"B5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0065-3527(06)66002-8","article-title":"In a nutshell: structure and assembly of the vaccinia virion.","volume":"66","author":"Condit","year":"2006","journal-title":"Adv. Virus Res."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005556","article-title":"Structurally optimized analogs of the retrograde trafficking inhibitor Retro-2cycl limit Leishmania infections.","volume":"11","author":"Craig","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1080\/13880209.2017.1310907","article-title":"Isolation and identification of compounds from Kalanchoe pinnata having human alphaherpesvirus and vaccinia virus antiviral activity.","volume":"55","author":"Cryer","year":"2017","journal-title":"Pharm. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4014\/jmb.1712.12052","article-title":"Antiviral effect of Retro-2.1 against Herpes simplex virus type 2 in vitro.","volume":"28","author":"Dai","year":"2018","journal-title":"J. Microbiol. Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/jac\/dku545","article-title":"ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.","volume":"70","author":"Duraffour","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.15585\/mmwr.mm6710a5","article-title":"Emergence of Monkeypox - West and Central Africa, 1970-2017.","volume":"67","author":"Durski","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1006\/viro.1993.1302","article-title":"The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.","volume":"194","author":"Engelstad","year":"1993","journal-title":"Virology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3201\/eid2505.190076","article-title":"Diagnosis of imported monkeypox Israel, 2018.","volume":"25","author":"Erez","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"B13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4612-3900-0_10","article-title":"Poxviridae: the poxviruses","author":"Fenner","year":"1988","journal-title":"Laboratory Diagnosis of Infectious Diseases Principles and Practice: VOLUME II Viral, Rickettsial, and Chlamydial Diseases"},{"key":"B14","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1073\/pnas.0912134107","article-title":"Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice.","volume":"107","author":"Grosenbach","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/fvl.11.27","article-title":"Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.","volume":"6","author":"Grosenbach","year":"2011","journal-title":"Future Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"10120","DOI":"10.1128\/JVI.01464-16","article-title":"Vaccinia virus uses retromer-independent cellular retrograde transport pathways to facilitate the wrapping of intracellular mature virions during virus morphogenesis.","volume":"90","author":"Harrison","year":"2016","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"10959","DOI":"10.1128\/JVI.01195-15","article-title":"Out of the reservoir: phenotypic and genotypic characterization of a novel cowpox virus isolated from a common vole.","volume":"89","author":"Hoffmann","year":"2015","journal-title":"J. Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jviromet.2008.02.009","article-title":"A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.","volume":"150","author":"Johnson","year":"2008","journal-title":"J. Virol. Methods"},{"key":"B19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections.","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3201\/eid2409.171283","article-title":"Novel Orthopoxvirus and lethal disease in cat.","volume":"24","author":"Lanave","year":"2018","journal-title":"Italy. Emerg. Infect. Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/infdis\/jis510","article-title":"Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin ST-246, and CMX001.","volume":"206","author":"Lederman","year":"2012","journal-title":"J. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.antiviral.2013.03.020","article-title":"Curing a viral infection by targeting the host: the example of cyclophilin inhibitors.","volume":"99","author":"Lin","year":"2013","journal-title":"Antiviral Res."},{"key":"B23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2005.09.037","article-title":"Poxvirus entry and membrane fusion.","volume":"344","author":"Moss","year":"2006","journal-title":"Virology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1021\/jm4002346","article-title":"N-methyldihydroquinazolinone derivatives of Retro-2 with enhanced efficacy against Shiga toxin.","volume":"56","author":"Noel","year":"2013","journal-title":"J. Med. Chem."},{"key":"B25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1099\/0022-1317-50-1-89","article-title":"Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.","volume":"50","author":"Payne","year":"1980","journal-title":"J. Gen. Virol."},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00011-17","article-title":"Monkeypox virus host factor screen using haploid cells identifies essential role of GARP complex in extracellular virus formation.","volume":"91","author":"Realegeno","year":"2017","journal-title":"J. Virol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere.","volume":"350","author":"Reed","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8891","DOI":"10.1128\/JVI.01114-16","article-title":"Retrograde transport from early endosomes to the trans-Golgi network enables membrane wrapping and egress of vaccinia virus virions.","volume":"90","author":"Sivan","year":"2016","journal-title":"J. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus.","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.1128\/JVI.02173-10","article-title":"Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus.","volume":"85","author":"Smith","year":"2011","journal-title":"J. Virol."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-3-26","article-title":"Retrograde transport pathways utilised by viruses and protein toxins.","volume":"3","author":"Spooner","year":"2006","journal-title":"Virol. J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/cid\/cix219","article-title":"Novel Orthopoxvirus Infection in an Alaska Resident.","volume":"64","author":"Springer","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.38.1800509","article-title":"Two cases of monkeypox imported to the United Kingdom, September 2018.","volume":"23","author":"Vaughan","year":"2018","journal-title":"Euro. Surveill."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMoa1407647","article-title":"Human infection with a zoonotic orthopoxvirus in the country of Georgia.","volume":"372","author":"Vora","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1128\/JVI.67.8.4732-4741.1993","article-title":"Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.","volume":"67","author":"Wolffe","year":"1993","journal-title":"J. Virol."},{"key":"B36","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T07:34:01Z","timestamp":1587627241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":36,"alternative-id":["10.3389\/fmicb.2020.00603"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00603","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"article-number":"603"}}